$88.88
0.41% today
NYSE, Nov 26, 12:39 am CET
ISIN
US1011371077
Symbol
BSX

Boston Scientific Target price 2024 - Analyst rating & recommendation

Boston Scientific Classifications & Recommendation:

Buy
83%
Hold
17%

Boston Scientific Price Target

Target Price $98.32
Price $89.25
Potential
Number of Estimates 28
28 Analysts have issued a price target Boston Scientific 2025 . The average Boston Scientific target price is $98.32. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 35 analysts: 29 Analysts recommend Boston Scientific to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Boston Scientific stock has an average upside potential 2025 of . Most analysts recommend the Boston Scientific stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 14.24 16.58
12.29% 16.45%
EBITDA Margin 23.71% 29.63%
1.61% 24.94%
Net Margin 11.07% 11.65%
111.76% 5.23%

28 Analysts have issued a sales forecast Boston Scientific 2024 . The average Boston Scientific sales estimate is

$16.6b
Unlock
. This is
4.23% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$16.7b 4.90%
Unlock
, the lowest is
$16.4b 3.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $14.2b 12.29%
2024
$16.6b 16.45%
Unlock
2025
$18.6b 12.19%
Unlock
2026
$20.5b 10.05%
Unlock
2027
$22.4b 9.53%
Unlock
2028
$24.3b 8.49%
Unlock

15 Analysts have issued an Boston Scientific EBITDA forecast 2024. The average Boston Scientific EBITDA estimate is

$4.9b
Unlock
. This is
27.36% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$5.2b 34.78%
Unlock
, the lowest is
$4.6b 18.92%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $3.4b 14.09%
2024
$4.9b 45.51%
Unlock
2025
$5.8b 17.94%
Unlock
2026
$6.4b 10.89%
Unlock
2027
$7.1b 10.84%
Unlock
2028
$7.7b 7.88%
Unlock

EBITDA Margin

2023 23.71% 1.61%
2024
29.63% 24.94%
Unlock
2025
31.15% 5.13%
Unlock
2026
31.39% 0.77%
Unlock
2027
31.76% 1.18%
Unlock
2028
31.59% 0.54%
Unlock

11 Boston Scientific Analysts have issued a net profit forecast 2024. The average Boston Scientific net profit estimate is

$1.9b
Unlock
. This is
8.34% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$2.1b 16.53%
Unlock
, the lowest is
$1.9b 5.78%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $1.6b 137.78%
2024
$1.9b 22.52%
Unlock
2025
$2.8b 46.78%
Unlock
2026
$3.6b 25.27%
Unlock
2027
$4.3b 20.15%
Unlock
2028
$4.7b 9.23%
Unlock

Net Margin

2023 11.07% 111.76%
2024
11.65% 5.23%
Unlock
2025
15.24% 30.82%
Unlock
2026
17.35% 13.85%
Unlock
2027
19.03% 9.68%
Unlock
2028
19.16% 0.68%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 1.07 1.31
137.78% 22.43%
P/E 68.08
EV/Sales 8.47

11 Analysts have issued a Boston Scientific forecast for earnings per share. The average Boston Scientific <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$1.31
Unlock
. This is
8.26% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.41 16.53%
Unlock
, the lowest is
$1.28 5.79%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $1.07 137.78%
2024
$1.31 22.43%
Unlock
2025
$1.92 46.56%
Unlock
2026
$2.41 25.52%
Unlock
2027
$2.90 20.33%
Unlock
2028
$3.16 8.97%
Unlock

P/E ratio

Current 73.82 8.34%
2024
68.08 7.78%
Unlock
2025
46.38 31.87%
Unlock
2026
37.03 20.16%
Unlock
2027
30.82 16.77%
Unlock
2028
28.21 8.47%
Unlock

Based on analysts' sales estimates for 2024, the Boston Scientific stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.83 35.02%
2024
8.47 4.07%
Unlock
2025
7.55 10.87%
Unlock
2026
6.86 9.13%
Unlock
2027
6.26 8.70%
Unlock
2028
5.77 7.83%
Unlock

P/S ratio

Current 8.27 39.56%
2024
7.93 4.06%
Unlock
2025
7.07 10.87%
Unlock
2026
6.42 9.13%
Unlock
2027
5.87 8.70%
Unlock
2028
5.41 7.83%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today